Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bile Acid and Lipid Metabolism in Patients With Drug-induced Acute Insulin Resistance

NCT05571670 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05571670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05571670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bile Acid and Lipid Metabolism in Patients With Drug-induced Acute Insulin Resistance
Lead sponsor
Columbia University
Phase
Observational
Overall status
Terminated
Start date
June 10, 2022
Completion date
June 10, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

akt gene mutation, cancer, insulin resistance, mtor gene mutation, pi3k gene mutation